Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason S Lewis

Showing results (141-150 of 359) with videos related to

Pageof 36
Sort By:
Journal of Inorganic Biochemistry|November 26, 2009
Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxiaPaul D Bonnitcha, Simon R Bayly, Mark B M Theobald, et al.
Plos One|January 30, 2010
Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumabJason P Holland, Eloisi Caldas-Lopes, Vadim Divilov, et al.
Nuclear Medicine and Biology|February 22, 2005
Investigation into 64Cu-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agentsPaul McQuade, Katherine E Martin, Thomas C Castle, et al.
Cancer Research|January 26, 2002
Copper-64-pyruvaldehyde-bis(N(4)-methylthiosemicarbazone) for the prevention of tumor growth at wound sites following laparoscopic surgery: monitoring therapy response with microPET and magnetic resonance imagingJason S Lewis, Judith M Connett, Joel R Garbow, et al.
Theranostics|February 12, 2020
The Influence of Glycans-Specific Bioconjugation on the FcγRI Binding and <i>In vivo</i> Performance of <sup>89</sup>Zr-DFO-PertuzumabDelphine Vivier, Kimberly Fung, Cindy Rodriguez, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|November 29, 2007
Synthesis, in vitro and in vivo characterization of (64)Cu(I) complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligandsSimone Alidori, Giancarlo Gioia Lobbia, Grazia Papini, et al.
Molecular Pharmaceutics|March 27, 2019
Toward the Optimization of Click-Mediated Pretargeted RadioimmunotherapyRosemery Membreno, Outi M Keinänen, Brendon E Cook, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2016
Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast CancersGary A Ulaner, Debra A Goldman, Mithat Gönen, et al.
Molecular Pharmaceutics|July 9, 2014
Targeting breast tumors with pH (low) insertion peptidesRamona-Cosmina Adochite, Anna Moshnikova, Sean D Carlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2025
Pretargeted Trop-2 immunoPET for rapid, selective detection of pancreatic tumorsEdwin C Pratt, Komal Mandleywala, David Bauer, et al.
Pageof 36

Showing results (141-150 of 359) with videos related to

Sort By:
Pageof 36
Journal of Inorganic Biochemistry|November 26, 2009
Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxiaPaul D Bonnitcha, Simon R Bayly, Mark B M Theobald, et al.
Plos One|January 30, 2010
Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumabJason P Holland, Eloisi Caldas-Lopes, Vadim Divilov, et al.
Nuclear Medicine and Biology|February 22, 2005
Investigation into 64Cu-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agentsPaul McQuade, Katherine E Martin, Thomas C Castle, et al.
Cancer Research|January 26, 2002
Copper-64-pyruvaldehyde-bis(N(4)-methylthiosemicarbazone) for the prevention of tumor growth at wound sites following laparoscopic surgery: monitoring therapy response with microPET and magnetic resonance imagingJason S Lewis, Judith M Connett, Joel R Garbow, et al.
Theranostics|February 12, 2020
The Influence of Glycans-Specific Bioconjugation on the FcγRI Binding and <i>In vivo</i> Performance of <sup>89</sup>Zr-DFO-PertuzumabDelphine Vivier, Kimberly Fung, Cindy Rodriguez, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|November 29, 2007
Synthesis, in vitro and in vivo characterization of (64)Cu(I) complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligandsSimone Alidori, Giancarlo Gioia Lobbia, Grazia Papini, et al.
Molecular Pharmaceutics|March 27, 2019
Toward the Optimization of Click-Mediated Pretargeted RadioimmunotherapyRosemery Membreno, Outi M Keinänen, Brendon E Cook, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2016
Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast CancersGary A Ulaner, Debra A Goldman, Mithat Gönen, et al.
Molecular Pharmaceutics|July 9, 2014
Targeting breast tumors with pH (low) insertion peptidesRamona-Cosmina Adochite, Anna Moshnikova, Sean D Carlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2025
Pretargeted Trop-2 immunoPET for rapid, selective detection of pancreatic tumorsEdwin C Pratt, Komal Mandleywala, David Bauer, et al.
Pageof 36